Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Sep;110(1):80-5.
doi: 10.1046/j.1365-2567.2003.01707.x.

Inhibition of DC-SIGN-mediated trans infection of T cells by mannose-binding lectin

Affiliations

Inhibition of DC-SIGN-mediated trans infection of T cells by mannose-binding lectin

Gregory T Spear et al. Immunology. 2003 Sep.

Abstract

Some dendritic cells (DC) express a cell-surface lectin called 'dendritic cell-specific intracellular adhesion molecule 3 (ICAM-3)-grabbing non-integrin' (DC-SIGN). DC-SIGN has been shown to mediate a type of infection called 'trans' infection, where DC bind human immunodeficiency virus (HIV) and efficiently transfer the virus to T cells. We investigated the possibility that mannose-binding lectin (MBL), a soluble lectin that functions as a recognition molecule in innate immunity and that binds to HIV, could block trans infection mediated by DC-SIGN. Binding studies with glycoprotein (gp)120/gp41-positive and -negative virus preparations suggested that DC-SIGN and MBL bind primarily to glycans on gp120/gp41, as opposed to glycans on host-cell-derived proteins, indicating a close overlap in the binding site of the two lectins and supporting the notion that MBL could prevent binding of HIV to DC-SIGN. Preincubation of X4, R5 or dual-tropic HIV strains with MBL prevented DC-SIGN-mediated trans infection of T cells. The mechanism of MBL blocking trans infection of T cells was at least partly caused by blocking of virus binding to DC-SIGN positive cells. This study shows that MBL prevents DC-SIGN-mediated trans infection of T cells in vitro and suggests that in infected persons, MBL may inhibit DC-SIGN-mediated uptake and spread of HIV.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mannose-binding lectin (MBL) structure and dendritic cell-specific intracellular adhesion molecule 3 (ICAM-3)-grabbing non-integrin (DC-SIGN) expression by THP cells. (a) Purified recombinant MBL and serum MBL were analysed by Western blotting with anti-MBL monoclonal antibody (mAb) after electrophoresis on 8% polyacrylamide gels under non-reducing conditions. (b) Expression of DC-SIGN by DC-SIGN-positive (THPD) and -negative (THP) THP cells was determined by flow cytometric analysis of cells stained with either DC28 anti-DC-SIGN mAb (Ab) or an isotype-matched control mAb (C) followed by incubation with fluorescein isothiocyanate (FITC)-labelled goat anti-mouse IgG.
Figure 2
Figure 2
Binding of human immunodeficiency virus (HIV) to dendritic cell-specific intracellular adhesion molecule 3 (ICAM-3)-grabbing non-integrin (DC-SIGN) and mannose-binding lectin (MBL) is dependent on glycoprotein (gp)120/gp41 glycans. Equal amounts (5000 pg of p24) of either gp120/gp41-positive (Env+) or gp120/gp41-negative (Env–) virus were incubated with THP cells expressing DC-SIGN (DC-SIGN) or in MBL-coated microtitre wells (MBL). After incubation, unbound virus was removed by washing, and bound virus detected by p24 enzyme-linked immunosorbent assay (ELISA) after lysis in detergent. Data shown represent mean values ± standard deviation (SD) from one experiment representative of three different experiments.
Figure 3
Figure 3
Mannose-binding lectin (MBL) inhibits human immunodeficiency virus (HIV) trans infection and binding mediated by dendritic cell-specific intracellular adhesion molecule 3 (ICAM-3)-grabbing non-integrin (DC-SIGN). HIVGP (a) or HIVBAL (b) were incubated with THP cells expressing DC-SIGN (THPD) or DC-SIGN-negative THP cells (THP) either in the absence of inhibitors or in the presence of mannan (THPD + Man) or the presence of MBL. Unbound virus was removed by washing and THP cells were then co-cultured with phytohaemagglutinin (PHA)-stimulated peripheral blood mononuclear cells (PBMCs). The level of p24 in culture supernatants was measured on day 10. (c) and (d) THP cells were incubated with virus as in (a) and (b) and the amount of p24 antigen associated with THPD and THP cells was determined by enzyme-linked immunosorbent assay (ELISA) after lysis in detergent. Data shown represent mean values ± standard deviation (SD) from one experiment representative of three different experiments (for HIVGP) or two different experiments (for HIVBAL).
Figure 4
Figure 4
Comparison of mannose-binding lectin (MBL) with other compounds for inhibition of human immunodeficiency virus (HIV) binding to dendritic cell-specific intracellular adhesion molecule 3 (ICAM-3)-grabbing non-integrin (DC-SIGN)-positive cells. THP cells expressing DC-SIGN were incubated with virus in the presence of MBL, bovine serum albumin, transferrin, phytohaemagglutinin (PHA) or Cyanovirin-N, and the amount of p24 antigen associated with cells was determined. Data shown represent mean values from one experiment representative of three different experiments.

Similar articles

Cited by

References

    1. Geijtenbeek TB, Krooshoop DJ, Bleijs DA, et al. DC-SIGN–ICAM−2 interaction mediates dendritic cell trafficking. Nat Immunol. 2000;1:353. - PubMed
    1. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y, Figdor CG. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell. 2000;100:575. - PubMed
    1. Figdor CG, van Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and Langerhans' cells. Nat Rev Immunol. 2002;2:77. - PubMed
    1. Geijtenbeek TB, Kwon DS, Torensma R, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 2000;100:587. - PubMed
    1. Pohlmann S, Baribaud F, Lee B, et al. DC–SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus. J Virol. 2001;75:4664. - PMC - PubMed

Publication types

Substances